Quaker Chemical Corp

Long- and medium-term biases remain bullish under Stage 2 advancing, but price is now extended above rising EMAs with extreme overbought readings (RSI and Options Score). Without mean-reversion permission or a Lockout Rally, execution is deferred until a pullback into support zones—such as the 9/21 EMA band or the recent breakout level—provides a lower-risk entry.

• ↑APAC sales up 25% YoY, driven by double-digit volume growth and acquisitions
• ↑Net sales rose 8% to $480M, with organic volumes up 3% and global share gains
• ↓Profitability under pressure from raw material inflation and higher SG&A costs